Literature DB >> 28734267

Status epilepticus-related etiology, incidence and mortality: A meta-analysis.

Rui-Juan Lv1, Qun Wang1, Tao Cui1, Fei Zhu1, Xiao-Qiu Shao2.   

Abstract

Status epilepticus (SE) is a severe medical condition. To determine its epidemiology and outcome of SE, we performed a meta-analysis to investigate the etiology, incidence and mortality of SE. We searched PubMed and Embase between Jan 1, 2000, and Oct 31, 2016, with no regional restrictions, for observational studies of the etiology, incidence and mortality of SE. Forty-three studies were included in the meta-analysis. The pooled crude annual incidence rate, the pooled case fatality rate and the pooled crude annual mortality rate of SE were 12.6/100,000 (95% CI: 10.0-15.3), 14.9% (95% CI: 11.7-118.7) and 0.98/100,000 (95% CI: 0.74-1.22), respectively. Elderly subjects with SE had a higher case fatality rate (28.4% (95% CI: 17.7-42.3)) and crude annual incidence rate (27.1% (95% CI: 15.8-38.2)). The most important etiology-specific attributable fraction of patients with SE was acute symptomatic etiology (OR 0.411, 95% CI: 0.315-0.507). Age and economic income contributed to differences in SE incidence and short-term case fatality rate.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Case fatality rate; Crude annual incidence rate; Etiology; Meta-analysis; Status epilepticus

Mesh:

Year:  2017        PMID: 28734267     DOI: 10.1016/j.eplepsyres.2017.07.006

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  20 in total

1.  Adult neurogenesis in the mouse dentate gyrus protects the hippocampus from neuronal injury following severe seizures.

Authors:  Swati Jain; John J LaFrancois; Justin J Botterill; David Alcantara-Gonzalez; Helen E Scharfman
Journal:  Hippocampus       Date:  2019-01-23       Impact factor: 3.899

2.  When aphasia is due to aphasic status epilepticus: a diagnostic challenge.

Authors:  Sonia Quintas; Juan Camilo Ródriguez-Carrillo; Rafael Toledano; María de Toledo; Francisco José Navacerrada Barrero; M Álvaro Berbís; Ana Beatriz Gago-Veiga
Journal:  Neurol Sci       Date:  2017-12-18       Impact factor: 3.307

Review 3.  Pathophysiology of convulsive status epilepticus.

Authors:  Iván Sánchez Fernández; Howard P Goodkin; Rod C Scott
Journal:  Seizure       Date:  2018-08-06       Impact factor: 3.184

4.  Pentylenetetrazole preconditioning attenuates severity of status epilepticus induced by lithium-pilocarpine in male rats: evaluation of opioid/NMDA receptors and nitric oxide pathway.

Authors:  Faezeh Eslami; Maryam Shayan; Arash Amanlou; Nastaran Rahimi; Pegah Dejban; Ahmad Reza Dehpour
Journal:  Pharmacol Rep       Date:  2022-07-24       Impact factor: 3.919

5.  Status epilepticus after intracranial neurosurgery: incidence and risk stratification by perioperative clinical features.

Authors:  Michael C Jin; Jonathon J Parker; Michael Zhang; Zack A Medress; Casey H Halpern; Gordon Li; John K Ratliff; Gerald A Grant; Robert S Fisher; Stephen Skirboll
Journal:  J Neurosurg       Date:  2021-05-14       Impact factor: 5.115

Review 6.  Updates in Refractory Status Epilepticus.

Authors:  Rohit Marawar; Maysaa Basha; Advait Mahulikar; Aaron Desai; Kushak Suchdev; Aashit Shah
Journal:  Crit Care Res Pract       Date:  2018-05-08

Review 7.  Super-Refractory Status Epilepticus: Prognosis and Recent Advances in Management.

Authors:  Batool F Kirmani; Katherine Au; Lena Ayari; Marita John; Padmashri Shetty; Robert J Delorenzo
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

Review 8.  Management of Autoimmune Status Epilepticus.

Authors:  Batool F Kirmani; Donald Barr; Diana Mungall Robinson; Zachary Pranske; Ekokobe Fonkem; Jared Benge; Jason H Huang; Geoffrey Ling
Journal:  Front Neurol       Date:  2018-05-09       Impact factor: 4.003

9.  Long-term outcomes of status epilepticus: A critical assessment.

Authors:  Claudine Sculier; Marina Gaínza-Lein; Iván Sánchez Fernández; Tobias Loddenkemper
Journal:  Epilepsia       Date:  2018-08-26       Impact factor: 5.864

10.  One- to 10-year Status Epilepticus Mortality (SEM) score after 30 days of hospital discharge: development and validation using competing risks analysis.

Authors:  Prapassara Sirikarn; Porjai Pattanittum; Somsak Tiamkao
Journal:  BMC Neurol       Date:  2019-12-01       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.